{"title":"南亚和东南亚区域的口腔癌，2022：发病率和死亡率。","authors":"Saman Warnakulasuriya, Adalberto M Filho","doi":"10.1111/odi.15369","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We present an epidemiological description of cancer of the lip, oral cavity, and oropharynx focused on South and South-East Asia by cancer site, sex, and population.</p><p><strong>Methods: </strong>The number of new cases and deaths from lip, oral cavity, and oropharynx cancers was extracted from GLOBOCAN 2022 and Cancer Incidence in Five Continents. We present age-standardized incidence and mortality rates (ASR) per 100,000 and temporal trends between 1992 and 2017 for four populations in the Region.</p><p><strong>Results: </strong>In 2022, there were 177,258 incident cases and 98,735 deaths from oral cancer in this region. ASR for lip and oral cancer in South and South-East Asia was highest in India (14.67), Sri Lanka (14.04), Bangladesh (13.61) and Pakistan (12.07) in males. The highest age-standardized mortality rates for lip and oral cancer were observed in India (8.17), Bangladesh (8.07) and Pakistan (7.74) for males.</p><p><strong>Conclusion: </strong>Incidence and mortality rates of oral cancer in South and South-East Asia are among the highest globally. 52% of total global deaths from oral cancer are reported from this region. Data suggest a persisting trend and an increase in the incidence of oral cavity cancer among Indian and Bangladeshi males.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oral Cancer in the South and South-East Asia Region, 2022: Incidence and Mortality.\",\"authors\":\"Saman Warnakulasuriya, Adalberto M Filho\",\"doi\":\"10.1111/odi.15369\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>We present an epidemiological description of cancer of the lip, oral cavity, and oropharynx focused on South and South-East Asia by cancer site, sex, and population.</p><p><strong>Methods: </strong>The number of new cases and deaths from lip, oral cavity, and oropharynx cancers was extracted from GLOBOCAN 2022 and Cancer Incidence in Five Continents. We present age-standardized incidence and mortality rates (ASR) per 100,000 and temporal trends between 1992 and 2017 for four populations in the Region.</p><p><strong>Results: </strong>In 2022, there were 177,258 incident cases and 98,735 deaths from oral cancer in this region. ASR for lip and oral cancer in South and South-East Asia was highest in India (14.67), Sri Lanka (14.04), Bangladesh (13.61) and Pakistan (12.07) in males. The highest age-standardized mortality rates for lip and oral cancer were observed in India (8.17), Bangladesh (8.07) and Pakistan (7.74) for males.</p><p><strong>Conclusion: </strong>Incidence and mortality rates of oral cancer in South and South-East Asia are among the highest globally. 52% of total global deaths from oral cancer are reported from this region. Data suggest a persisting trend and an increase in the incidence of oral cavity cancer among Indian and Bangladeshi males.</p>\",\"PeriodicalId\":19615,\"journal\":{\"name\":\"Oral diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/odi.15369\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/odi.15369","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Oral Cancer in the South and South-East Asia Region, 2022: Incidence and Mortality.
Introduction: We present an epidemiological description of cancer of the lip, oral cavity, and oropharynx focused on South and South-East Asia by cancer site, sex, and population.
Methods: The number of new cases and deaths from lip, oral cavity, and oropharynx cancers was extracted from GLOBOCAN 2022 and Cancer Incidence in Five Continents. We present age-standardized incidence and mortality rates (ASR) per 100,000 and temporal trends between 1992 and 2017 for four populations in the Region.
Results: In 2022, there were 177,258 incident cases and 98,735 deaths from oral cancer in this region. ASR for lip and oral cancer in South and South-East Asia was highest in India (14.67), Sri Lanka (14.04), Bangladesh (13.61) and Pakistan (12.07) in males. The highest age-standardized mortality rates for lip and oral cancer were observed in India (8.17), Bangladesh (8.07) and Pakistan (7.74) for males.
Conclusion: Incidence and mortality rates of oral cancer in South and South-East Asia are among the highest globally. 52% of total global deaths from oral cancer are reported from this region. Data suggest a persisting trend and an increase in the incidence of oral cavity cancer among Indian and Bangladeshi males.
期刊介绍：
Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, edited by leaders in the field, Professor Giovanni Lodi (Editor-in-Chief, Milan, Italy), Professor Stefano Petti (Deputy Editor, Rome, Italy) and Associate Professor Gulshan Sunavala-Dossabhoy (Deputy Editor, Shreveport, LA, USA). The journal is pre-eminent in oral medicine. Oral Diseases specifically strives to link often-isolated areas of dentistry and medicine through broad-based scholarship that includes well-designed and controlled clinical research, analytical epidemiology, and the translation of basic science in pre-clinical studies. The journal typically publishes articles relevant to many related medical specialties including especially dermatology, gastroenterology, hematology, immunology, infectious diseases, neuropsychiatry, oncology and otolaryngology. The essential requirement is that all submitted research is hypothesis-driven, with significant positive and negative results both welcomed. Equal publication emphasis is placed on etiology, pathogenesis, diagnosis, prevention and treatment.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
